BridgeBio Pharma Inc.

BridgeBio Pharma Inc. (BBIO) — Form 8-K: Current report

8-KBBIOFiled Oct 29, 2026, 12:03 PM ET· Period Oct 29, 2026

About this filing

BridgeBio Pharma Inc. (BBIO) filed an 8-K on Oct 29, 2026 reporting results of operations (earnings) (Item 2.02), with exhibits (Item 9.01).

View original filing on SEC.gov

Key facts

Item 2.02 · Results of operations (earnings)
Item 9.01 · Financial statements and exhibits

More BBIO filings

SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Nov 12, 2026
4
Insider transaction
Filed Nov 3, 2026
10-Q
Quarterly report
Filed Oct 29, 2026
SC 13G
Ownership over 5% (passive)
Filed Oct 27, 2026
8-K
Current report
Filed Oct 13, 2026
4
Insider transaction
Filed Sep 21, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.